{
    "nctId": "NCT04473378",
    "briefTitle": "Glucose Monitoring During Chemotherapy",
    "officialTitle": "Pilot Study of Glucose Monitoring to Determine Rates of Hyperglycemia During Chemotherapy for Early Stage Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer, Hyperglycemia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 22,
    "primaryOutcomeMeasure": "Prevalence of hyperglycemia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years\n* History of stage I-III breast cancer\n* Patient scheduled to receive adjuvant or neoadjuvant chemotherapy\n* Signed informed consent\n\nExclusion Criteria:\n\n* Current treatment with insulin\n* Current treatment with non-topical steroids, with the exception of steroid treatment as a supportive chemotherapy medication\n* Inability to provide informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}